 |
|
|
Myozyme® (alglucosidase alfa)
Bibliographical Information:
Drug Name
|
Generic Name
|
Studied Indications or Disease
|
Approved U.S. Drug Label
|
Myozyme®
|
Alglucosidase alfa
|
Pompe disease
Glycogen Storage Disease Type II
Acid Maltase Deficiency Disease
Glycogenesis 2
|
Prescribing Info
|
Protocol AGLU01602
Kishnani, P, Corzo, D, Nicolino, M, et al. Recombinant Human Acid a-Glucosidase: Major Clinical Benefits in Infantile-Onset Pompe Disease. NEUROLOGY 2007;68(2): 99-109
Protocol AGLU01702
No associated publications
Protocol AGLU02804
No associated publications
|
|
 |
|
|
Contact Information
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142
T:617 252 7500
F:617 252 7600
Contact Us
|
|
|
|
|
Home
